Moonlight Bio
- Business Model
- B2B
- Website
- moonlightbio.us
- Last Round
- SeedJan 2023
- Rounds
- 1
About
Biotech company developing proprietary cell therapy potency enhancement technologies for cancer treatment.
Summary
Moonlight Bio is a Biotech company based in United States. Its most recent funding was a Seed round in Jan 2023. Investors include ARCH Venture Partners, Venrock and Parker Institute for Cancer Immunotherapy.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2023
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...